Join Free For Buyer|Sign In

Professional Online Trade Platform for API, Preparation and Pharmaceutical Machinery and Equipment_EN-CPhI.cn

You are here:  Home >>  News >>  Research & Development >>  New psoriasis drug study yields positive results: Dr Reddy’s

New psoriasis drug study yields positive results: Dr Reddy’s

June 14, 2019 By expressbpd

According to a press release from the city-based drug-maker, the detailed safety and efficacy data from the study would be presented in future dermatology conferences

Dr Reddy’s Laboratories announced that it has obtained positive results in the phase-IIb study of its oral molecule PPC-06 (formerly referred to as XP23829) in patients with moderate to severe plaque psoriasis.

According to a press release from the city-based drug-maker, the detailed safety and efficacy data from the study would be presented in future dermatology conferences.

Senior vice-president and head, proprietary products business of the company, Anil Namboodiripad said PPC-06 is an oral molecule with a novel mechanism of action that has the potential to address unmet medical needs of psoriasis patients.

“The top-line data we are reporting today support our belief that PPC-06 may become the first approved oral prodrug of mono methyl fumarate (MMF) for treatment of moderate to severe plaque psoriasis in the US,” the official said.

Further clinical development requirements would be discussed with the US FDA to support the approval of this product, he added.

The most common adverse events (AEs) reported were lymphocytopenia, eosinophilia and gastro-intestinal (GI) disorders, such as diarrhoea, nausea, abdominal pain and vomiting.

“Given the positive clinical data in this study, PPC-06 may have a potential to serve as an important therapeutic option for psoriasis patients in a market with limited oral treatments. We thank all the patients, investigators and study staff whose ongoing participation helped us achieve this target, said Sagar Munjal, chief medical officer of Promius Pharma, the US subsidiary of Dr Reddy’s.

Readers'Comments
Add a comment
Click here to Login or to Register for free. You will be taken back to your selected item after Login/Registration.
More>> MarketNews
More>> Editors’Picks
More>> TopStories
More>> HotTags
Follow Us
CPhI Online Trade Platform: Worldwide|English|中国站
Customer Service:  86-400 610 1188 (9: 00-18: 00, Mon-Fri)
About Us| Contact Us| Terms of Services| Privacy Policy| Intellectual Property Statement| Links | Site Map
Copyright 2006-20 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved). ICP 05034851-53
客服
live chat